SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Trials and Tribulations:Emerging Issues in Designing Economic Evaluations Alongside Clinical Trials
11 references·0 citing·39 second hop
Trials and Tribulations:Emerging Issues in Designing Economic Evaluations Alongside Clinical Trials (1998)Trials and Tribulations:Emerging Issues i…Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? (1996)Economic evaluation of pharma…Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem (1996)Confidence intervals for cost…A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials (1996)A Strategy for Collecting Pha…A Multinational Economic Evaluation of rhDNase in the Treatment of Cystic Fibrosis (1996)A Multinational Economic Eval…In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)In Search of Power and Signif…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Costs, effects and C/E‐ratios…Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. (1993)Guidelines for the adoption o…Issues in the Cross-National Assessment of Health Technology (1992)Issues in the Cross-National …How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Economic Analysis in Randomized Control Trials (1992)Economic Analysis in Randomiz…Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues (1991)Economic Analysis Alongside C…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents (1989)QALYs and the equity-efficiency trade-off (1991)Assessing the costs of healthcare technologies in clinical trials. (1999)Cost effectiveness analysis in health care: contraindications (2002)Canʼt Get No Satisfaction? Will Pay for Performance Help? (2010)Alternative to Mental Hospital Treatment (1980)A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument (1993)A study of the quality of life and cost-utility of renal transplantation (1996)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Clinical decision analysis (2005)Methods for the Economic Evaluation of Health Care Programmes (2005)The Distinction Between Cost and Charges (1982)Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook (1998)Design Issues for Conducting Cost-Effectiveness Analyses Alongside Clinical Trials (2001)A method for assessing the quality of a randomized control trial (1981)Recommendations for Reporting Cost-effectiveness Analyses (1996)A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" Studies (2000)Cost-Benefit Analysis (2020)A Guide to Simulation (1983)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Meta-Analysis in Clinical Research (1987)Utility approach to measuring health-related quality of life (1987)Factors that limit the quality, number and progress of randomised controlled trials. (1999)Introducing economic and quality of life measurements into clinical studies (2001)Methods for the economic evaluation of health care programmes (1987)Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability (2005)Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation (1999)Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? (1999)Testing the Validity of Cost-Effectiveness Models (2000)Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations? (2005)
this work references cited by second hop

References

  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1994Costs, effects and C/E‐ratios alongside a clinical trial963 cited
  • 1994In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care404 cited
  • 1991Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues337 cited
  • 1996Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem189 cited
  • 1992Economic Analysis in Randomized Control Trials188 cited
  • 1993Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.173 cited
  • 1992Issues in the Cross-National Assessment of Health Technology160 cited
  • 1996Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?115 cited
  • 1996A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials50 cited
  • 1996A Multinational Economic Evaluation of rhDNase in the Treatment of Cystic Fibrosis49 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work